Shareholder Information
Investor Overview
NovaBay Pharmaceuticals is a clinical stage company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections. The company’s Aganocide compounds mimic the body’s immune system, acting rapidly and effectively to defeat multi-drug resistant pathogens without causing resistance. NovaBay’s lead Aganocide compound is in Phase 2 clinical testing for treating Pink Eye, Impetigo and Catheter-Associated Urinary Tract Infection.
The company has significant corporate partnerships with Alcon, the world’s leading ophthalmology company, and Galderma S.A., a global pharmaceutical firm dedicated to dermatology. NovaBay has also retained proprietary early stage programs addressing large markets such as onychomychosis, or nail fungus, and common cold.
Transfer Agent
The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. with the following contact information:
For standard US postal mail
Computershare Trust Company, N.A.
Po Box 43070
Providence, RI 02940-3070
For overnight/express delivery
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
For DWAC instructions provided to brokers
FAST Transfer Agent number – 50173
Telephone and Fax
Toll free in the US +1 800 962 4284
Telephone +1 303-262-0600
Fax +1 303-262-0700
Website
www.computershare.com
eMail inquiries
web.queries@computershare.com
Theresa Granados
(510) 899-8870
